Nanotechnology‐Based Targeted Drug Delivery: An Emerging Tool to Overcome Tuberculosis-Reference-Cited by-同舟云学术

Nanotechnology‐Based Targeted Drug Delivery: An Emerging Tool to Overcome Tuberculosis

Published:2020-10-19 Issue:1 Volume:4 Page:2000113
ISSN:2366-3987
Container-title:Advanced Therapeutics
language:en
Short-container-title:Adv. Therap.

Author:

Baranyai Zsuzsa¹^ORCID,Soria‐Carrera Héctor¹²^ORCID,Alleva Maria¹^ORCID,Millán‐Placer Ana C.³⁴^ORCID,Lucía Ainhoa³⁴⁵⁶^ORCID,Martín‐Rapún Rafael¹⁷²^ORCID,Aínsa José A.³⁴⁵⁶^ORCID,la Fuente Jesús M.¹²^ORCID

Affiliation:

1. Instituto de Nanociencia y Materiales de Aragón (INMA) CSIC–Universidad de Zaragoza C/ Mariano Esquillor s/n Zaragoza 50018 Spain

2. Biomateriales y Nanomedicina (CIBER‐BBN), Instituto de Salud Carlos III CIBER de Bioingeniería Madrid 28029 Spain

3. Departamento de Microbiología, Facultad de Medicina Universidad de Zaragoza C/ Domingo Miral s/n Zaragoza 50009 Spain

4. Instituto de Investigación Sanitaria Aragón (IIS‐Aragón) Zaragoza 50009 Spain

5. Instituto de Biocomputación y Física de Sistemas Complejos (BIFI) Universidad de Zaragoza C/ Mariano Esquillor s/n Zaragoza 50018 Spain

6. CIBER de Enfermedades Respiratorias (CIBERES) Instituto de Salud Carlos III Madrid 28029 Spain

7. Departamento de Química Orgánica Facultad de Ciencias Universidad de Zaragoza Zaragoza 50009 Spain

Funder

H2020 Marie Skłodowska-Curie Actions

Publisher

Wiley

Subject

Pharmacology (medical),Biochemistry, medical,Genetics(clinical),Pharmaceutical Science,Pharmacology,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/adtp.202000113

Reference209 articles.

1. Latent Mycobacterium tuberculosis Infection

2. Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Delamanid proliposomal powder aerosols targeting alveolar macrophages for treatment of pulmonary extensively drug-resistant tuberculosis treatment: Bioactivity, biocompatibility, and structure elucidation;Journal of Drug Delivery Science and Technology;2024-10

2. Nano-Medicine for Treatment of Tuberculosis, Promising Approaches Against Antimicrobial Resistance;Current Microbiology;2024-08-24

3. Quality by design (QbD) approach-based development of optimized nanocarrier to achieve quality target product profile (QTPP)-targeted lymphatic delivery;Nanotechnology;2024-04-10

4. Nanotechnological innovations in paediatric tuberculosis management: current trends and future prospects;Frontiers in Drug Delivery;2024-01-08

5. Nanomedicine drug delivery in South Africa: a retrospective study on research, funding and collaboration;Frontiers in Pharmacology;2024-01-03